| Application no. and date | 99968627.2 (espacenet) (Federated) (European Patent Register), 19990909 | | Patent/reg. no. and date | DK/EP 1109558, 20020522 | | Publication date | 20010627 | | Priority no. and date | US 99804 P, 19980910, US 321522, 19990527 | | EP pub. no. and date |
EP 1109558 20010627 | | Effective date | | | Applicant/owner | Gilead Sciences, Inc., a Delaware Corporation, 333 Lakeside Drive, Foster City
California 94404, US | | Applicant ref. no. | P80705510DK00F | | Inventor | WOLFF, Andrew, A., 1140 Lawton Street
San Francisco, CA 94304, US,
BAKER, Fiona, Pandova, 1 Aston Grove
Dunfermline KY11 4LE, GB,
LANGRIDGE, John, Yale Cottage,
The Plant
Llandegla,
Wrexham, GB | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/495 (2006.01) , A61K 9/20 (2006.01) | | Title | Ranolazinformuleringer med langvarig frigivelse | | Int. application no. | US1999020967 | | Int. publication no. | WO2000013686 | | Related patent (certificate) | CA 2008 00051 | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
